Skip to content
2000
Volume 14, Issue 1
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background: Adverse cardiorespiratory events are associated with midazolam continuous IV infusion, used for sedation. History: Here we are reporting a case of 5 year old male child suffering from diphtheria induced airway obstruction, and myocarditis, who received midazolam in the form of IV infusion for sedation while undergoing mechanical ventilation for respiratory failure. Adverse Event: Six hours after starting midazolam infusion he started developing pulsus bigeminus and bradycardia and eventual death after two hours. Conclusion: Midazolam, although considered one of the safest drugs, need to be used cautiously in a child with myocarditis, because of the possible cardiotoxic effect in an already affected heart.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886313666181105122154
2019-03-01
2025-07-12
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886313666181105122154
Loading

  • Article Type:
    Case Report
Keyword(s): bradycardia; Cardio-toxicity; diphtheria; midazolam; myocarditis; pulsus bigeminus
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test